DOCSLIB.ORG

Glyceraldehyde-3-Phosphate Dehydrogenase on the Surface of Group a Streptococci Is Also an ADP-Ribosylating Enzyme VUAYKUMAR PANCHOLI* and VINCENT A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Glyceraldehyde-3-Phosphate Dehydrogenase on the Surface of Group a Streptococci Is Also an ADP-Ribosylating Enzyme VUAYKUMAR PANCHOLI* and VINCENT A Proc. Natl. Acad. Sci. USA Vol. 90, pp. 8154-8158, September 1993 Microbiology Glyceraldehyde-3-phosphate dehydrogenase on the surface of group A streptococci is also an ADP-ribosylating enzyme VUAYKUMAR PANCHOLI* AND VINCENT A. FISCHETTI Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeiler University, 1230 York Avenue, New York, NY 10021 Communicated by Emil C. Gotschlich, May 19, 1993 ABSTRACT We recently identified an enzymatically ac- of this modification in prokaryotes is limited only to a few tive glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12; bacterial toxins such as diphtheria toxin (8), pseudomonas GAPDH) as a major protein on the surface of group A exotoxin A (9), pertussis toxin, and cholera toxin (10) and the streptococci (SDH), which exhibits multiple binding activity to regulation of nitrogenase activity in the photosynthetic bac- various mammalian proteins. We now report that the SDH teria Rhodospirillum rubrum (11). molecule also functions as an ADP-ribosylating enzyme, which, The ability of NO to stimulate ADP-ribosylation of eu- in the presence of NAD, is auto-ADP-ribosylated. In a crude karyotic GAPDH independent of cyclic GMP (3, 12) clearly cel wail extract of group A streptococci, SDH is the only distinguishes it from other known and characterized ADP- protein that is ADP-ribosylated. SDH found in the streptococ- ribosyl transferases that essentially involve activation of cal cytoplasmic fraction could not be ADP-ribosylated in the guanylate cyclase (10). Although the role of NO found in presence ofNAD. Treatment of ADP-ribosylated SDH with the activated macrophages is well established for its cytocidal cytoplasmic fraction removed the ADP-ribose from SDH, and cytostasis activity against fungal, helminthic, protozoal, suggesting the presence of an ADP-ribosyl hydrolase in the and bacterial pathogens (13), the role of NO-mediated ADP- cytoplasmic compartment. The covalent linkage ofADP-ribose ribosylation in bacteria and its implications in the pathogen- to SDH was stable to neutral hydroxylamine, sensitive to esis of the disease, however, have not been studied. HgCl2, and inhibitable by free cysteine, indicating that the Because eukaryotic GAPDHs have been found, in addition modification was at a cysteine residue of SDH. In addition to to their glycolytic activity, to perform various functions (see its auto-ADP-ribosylation activity, purified SDH or strepto- ref. 1) including ADP-ribosylation (3-5), we examined coccal cell wall extracts were able to transfer the ADP-ribose whether SDH also had ADP-ribosylating activity. We here moiety of NAD specifically to free cysteine, resulting in a true report that SDH is an ADP-ribosylating enzyme with auto- thioglycosidic linkage. Treatment ofpurified SDH or the crude ADP-ribosylating activity and the ability to specifically ADP- cell wall extract with sodium nitroprusside, which spontane- ribosylate free L-cysteine. The ADP-ribosylating activities of ously generates nitric oxide, was found to stimulate the ADP- SDH were also found to be significantly enhanced in the ribosylation of SDH in a time-dependent manner. ADP- presence of NO. Since, to our knowledge, such observations ribosylation and nitric oxide treatment inhibited the GAPDH for a surface molecule on a pathogenic organism have not activity of SDH. Since ADP-ribosylation and nitric oxide are been reported previously, our findings may open new ave- involved in signal transduction events, the ADP-ribosylating nues for understanding the pathogenesis of streptococcal activity of SDH may enable communication between host and disease. parasite during infection by group A streptococci. Streptococcal surface dehydrogenase (SDH), a 35.8-kDa MATERIALS AND METHODS protein, has recently been identified as one of the major Materials and Chemicals. SDH was purified from a strep- surface proteins ofgroup A streptococci (1). Structurally and tococcal cell wall extract (14, 15) as described (1). Rabbit functionally it is a member of the glyceraldehyde-3- polyclonal antisera against SDH were raised and affinity phosphate dehydrogenase (EC 1.2.1.12; GAPDH) family of purified as described (1). [a-32P]NAD (30 Ci/mmol; 1 Ci = 37 molecules. SDH is unique in its localization on a bacterial GBq) and [adenine-2,8-3H]NAD (25.9 Ci/mmol) were ob- surface and is found in all except a few streptococcal groups tained from NEN/DuPont. All other biochemicals were and in all group A streptococcal M types tested (1). SDH also obtained unless binds various mammalian proteins such as lysozyme, fibro- from Sigma, otherwise mentioned. nectin, and the cytoskeletal proteins actin and myosin. Re- Subcellular Fractionation of Streptococci. The cell walls cently, a structurally similar molecule has been shown to bind were digested using the amidase enzyme lysin in 30% raffi- plasmin (2). nose at pH 6.1, and the cytoplasm and membranes were Nitric oxide (NO) and NO-generating agents such as so- separated from the resulting protoplasts as described (14, 15). dium nitroprusside (SNP) were reported to stimulate mono- ADP-Ribosylation of SDH. The ADP-ribosylation of puri- ADP-ribosylation of a cytosolic 36-kDa protein found in fied SDH (20 pg) (1) was carried out in a reaction mixture (0.2 various human tissues such as platelets, liver, intestine, ml) containing 100 mM Tris HCl at pH 7.4, 10 mM dithio- heart, lung (3), brain (3, 4), and erythrocytes (5). This 36-kDa threitol, 1 mM NADP, 10 mM thymidine, and 10 uM protein has recently been identified to possess GAPDH [32P]NAD (ADPR buffer) for 1 hr at 37°C followed by the activity (4-6). Mono-ADP-ribosylation is a widely used addition of50 ,ul of 100o (wt/vol) chilled trichloroacetic acid method by which eukaryotic cells modify protein structure (TCA) to stop the reaction as described (5). The resulting and function (7). It is a covalent, posttranslational protein precipitates were washed, dried, and subjected to SDS/ modification in which the ADP-ribose moiety of NAD is PAGE (12% polyacrylamide) as described (14, 15). The gel transferred to an individual substrate (7). Our understanding Abbreviations: NO, nitric oxide; GAPDH, glyceraldehyde-3- phosphate dehydrogenase; SNP, sodium nitroprusside; SDH, strep- The publication costs of this article were defrayed in part by page charge tococcal surface dehydrogenase; TCA, trichloroacetic acid; PVDF, payment. This article must therefore be hereby marked "advertisement" poly(vinylidene difluoride). in accordance with 18 U.S.C. §1734 solely to indicate this fact. *To whom reprint requests should be addressed. 8154 Downloaded by guest on September 26, 2021 Microbiology: Pancholi and Fischetti Proc. Natl. Acad. Sci. USA 90 (1993) 8155 was dried and autoradiographed at -80°C. To locate specific and autoradiographed. In a similar set of experiments, ADP- ADP-ribosylating proteins, duplicate gels were electrotrans- ribosylation was performed using 200 ,ul of streptococcal cell ferred to nitrocellulose or poly(vinylidene difluoride) (PVDF) wall extract in ADPR buffer containing 10 p.M [32P]NAD membranes, Western blotted using anti-SDH antibodies, and incubated in the presence and absence of 2 mM SNP. autoradiographed. GAPDH Activity of ADP-Ribosylated SDH. GAPDH activ- In Vitro ADP-Ribosylation of SDH. To determine the spec- ity of purified SDH (5 pg) or ADP-ribosylated SDH (5 pg) ificity of the ADP-ribosylation of SDH in streptococci, two was determined in the presence of NAD and glyceraldehyde sets of experiments were performed: (i) the cell wall, cyto- 3-phosphate by measuring the absorbance at 340 nm, showing plasm, and membrane fractions, each adjusted to 1 mg of the conversion of NAD to NADH as described (1). protein per ml in 0.2 ml of ADPR buffer, were mixed with 10 To study the effect of NAD and SNP on the GAPDH ,uM [32P]NAD and (ii) to determine the ADP-ribosylating activity of SDH, (i) SDH (5 ,ug) was preincubated with activity of intact streptococci, an overnight culture of strep- different concentrations ofNAD for 1 hr prior to determining tococci (10 ml) was washed and resuspended in ADPR buffer its GAPDH activity, (ii) different concentrations ofSNP were (0.2 ml) containing 10 AM [32P]NAD as described above. added to SDH (5 ,ug) immediately prior to the addition of Bacterial cells were then thoroughly washed with 50 mM glyceraldehyde 3-phosphate, and (iii) SDH (5 p.g) was incu- sodium phosphate buffer at pH 6.1. The cells were digested bated with 2 mM SNP for different time periods prior to with lysin and fractionated as described above to locate the determining its GAPDH activity. GAPDH activity in all three ADP-ribosylated proteins in the cell wall, cytoplasm, and sets was carried out using a constant amount of NAD and membrane fractions. glyceraldehyde 3-phosphate as described above. Specificity and Inhibition of the ADP-Ribose-Protein Bond. The effect ofdifferent concentrations ofHgCl2 (0.063-2 mM) and neutral hydroxylamine (pH 7.4, 0.63-10 mM) on the RESULTS ADP-ribosylation reaction was determined by incorporating ADP-Ribosylation of SDH. To examine whether SDH has these reagents into the ADPR buffer prior to the addition of the same ADP-ribosylating activity as recently reported for [32P]NAD to carry out the reactions. After 30 min, the eukaryotic GAPDHs (3-5), purified SDH was incubated with samples were precipitated with cold TCA, dried, and sub- [32P]NAD in ADPR buffer. After SDS/PAGE and autorad- jected to electrophoresis and autoradiography. iography, SDH was found to have incorporated the radioac- Competitive Inhibition of ADP-Ribosylation of SDH with tivity from the labeled NAD (Fig. 1, lane 9). When the Free Amino Acids and ADP-Ribosyl Transferase Activity of molecules in the subcellular fractions representing cell wall- SDH. To verify the amino acid-specific ADP-ribosylation of associated cytoplasm and membrane components were sep- SDH, the ADP-ribosylation reaction was carried out in the arated by SDS/PAGE and Western blotted with affinity- presence of increasing concentrations of L-cysteine, L-histi- purified anti-SDH antibodies, SDH could be identified in all dine, L-arginine, and L-glutamic acid.
Load more

Recommended publications
  • Isocitrate Dehydrogenase Activity Assay Kit (MAK062)
    Isocitrate Dehydrogenase Activity Assay Kit Catalog Number MAK062 Storage Temperature –20 C TECHNICAL BULLETIN Product Description Developer 1 vl Isocitrate dehydrogenase (IDH) catalyzes the Catalog Number MAK062E conversion of isocitrate to -ketoglutarate. In eukaryotes, there are three isozymes of IDH, the IDH Positive Control (NADP+) 20 L mitochondrial IDH2 and IDH3, and the cytoplasmic/ Catalog Number MAK062F peroxisomal IDH1. All three IDH family members require the presence of a divalent cation (Mg2+ or Mn2+) NADH Standard, 0.5 mole 1 vl and either the electron-accepting cofactor NADP+ (IDH1 Catalog Number MAK062G and IDH2) or NAD+ (IDH3) for their enzymatic activity. IDH1 and IDH2 mutations resulting in neomorphic Reagents and Equipment Required but Not enzymatic activity are found in certain cancers such as Provided. glioblastoma, acute myeloid leukemia, and colon 96 well flat-bottom plate – It is recommended to use cancer. This neoactivity shows a change in the clear plates for colorimetric assays. substrate specificity resulting in the conversion of Spectrophotometric multiwell plate reader -ketoglutarate to 2-hydroxyglutarate. Mutations in IDH family members are also associated with Ollier disease Precautions and Disclaimer and Maffucci syndrome. This product is for R&D use only, not for drug, household, or other uses. Please consult the Material The Isocitrate Dehydrogenase Activity Assay kit Safety Data Sheet for information regarding hazards provides a simple and direct procedure for measuring and safe handling practices. + + + NADP -dependent, NAD -dependent, or both NADP + and NAD -dependent IDH activity in a variety of Preparation Instructions samples. IDH activity is determined using isocitrate as Briefly centrifuge vials before opening.
    [Show full text]
  • Isocitrate Dehydrogenase 1 (NADP+) (I5036)
    Isocitrate Dehydrogenase 1 (NADP+), human recombinant, expressed in Escherichia coli Catalog Number I5036 Storage Temperature –20 °C CAS RN 9028-48-2 IDH1 and IDH2 have frequent genetic alterations in EC 1.1.1.42 acute myeloid leukemia4 and better understanding of Systematic name: Isocitrate:NADP+ oxidoreductase these mutations may lead to an improvement of (decarboxylating) individual cancer risk assessment.6 In addition other studies have shown loss of IDH1 in bladder cancer Synonyms: IDH1, cytosolic NADP(+)-dependent patients during tumor development suggesting this may isocitrate dehydrogenase, isocitrate:NADP+ be involved in tumor progression and metastasis.7 oxidoreductase (decarboxylating), Isocitric Dehydrogenase, ICD1, PICD, IDPC, ICDC, This product is lyophilized from a solution containing oxalosuccinate decarboxylase Tris-HCl, pH 8.0, with trehalose, ammonium sulfate, and DTT. Product Description Isocitrate dehydrogenase (NADP+) [EC 1.1.1.42] is a Purity: ³90% (SDS-PAGE) Krebs cycle enzyme, which converts isocitrate to a-ketoglutarate. The flow of isocitrate through the Specific activity: ³80 units/mg protein glyoxylate bypass is regulated by phosphorylation of isocitrate dehydrogenase, which competes for a Unit definition: 1 unit corresponds to the amount of 1 common substrate (isocitrate) with isocitrate lyase. enzyme, which converts 1 mmole of DL-isocitrate to The activity of the enzyme is dependent on the a-ketoglutarate per minute at pH 7.4 and 37 °C (NADP formation of a magnesium or manganese-isocitrate as cofactor). The activity is measured by observing the 2 complex. reduction of NADP to NADPH at 340 nm in the 7 presence of 4 mM DL-isocitrate and 2 mM MnSO4.
    [Show full text]
  • Biochemistry Entry of Fructose and Galactose
    Paper : 04 Metabolism of carbohydrates Module : 06 Entry of Fructose and Galactose Dr. Vijaya Khader Dr. MC Varadaraj Principal Investigator Dr.S.K.Khare,Professor IIT Delhi. Paper Coordinator Dr. Ramesh Kothari,Professor UGC-CAS Department of Biosciences Saurashtra University, Rajkot-5, Gujarat-INDIA Dr. S. P. Singh, Professor Content Reviewer UGC-CAS Department of Biosciences Saurashtra University, Rajkot-5, Gujarat-INDIA Dr. Charmy Kothari, Assistant Professor Content Writer Department of Biotechnology Christ College, Affiliated to Saurashtra University, Rajkot-5, Gujarat-INDIA 1 Metabolism of Carbohydrates Biochemistry Entry of Fructose and Galactose Description of Module Subject Name Biochemistry Paper Name 04 Metabolism of Carbohydrates Module Name/Title 06 Entry of Fructose and Galactose 2 Metabolism of Carbohydrates Biochemistry Entry of Fructose and Galactose METABOLISM OF FRUCTOSE Objectives 1. To study the major pathway of fructose metabolism 2. To study specialized pathways of fructose metabolism 3. To study metabolism of galactose 4. To study disorders of galactose metabolism 3 Metabolism of Carbohydrates Biochemistry Entry of Fructose and Galactose Introduction Sucrose disaccharide contains glucose and fructose as monomers. Sucrose can be utilized as a major source of energy. Sucrose includes sugar beets, sugar cane, sorghum, maple sugar pineapple, ripe fruits and honey Corn syrup is recognized as high fructose corn syrup which gives the impression that it is very rich in fructose content but the difference between the fructose content in sucrose and high fructose corn syrup is only 5-10%. HFCS is rich in fructose because the sucrose extracted from the corn syrup is treated with the enzyme that converts some glucose in fructose which makes it more sweet.
    [Show full text]
  • (LCHAD) Deficiency / Mitochondrial Trifunctional Protein (MTF) Deficiency
    Long chain acyl-CoA dehydrogenase (LCHAD) deficiency / Mitochondrial trifunctional protein (MTF) deficiency Contact details Introduction Regional Genetics Service Long chain acyl-CoA dehydrogenase (LCHAD) deficiency / mitochondrial trifunctional Levels 4-6, Barclay House protein (MTF) deficiency is an autosomal recessive disorder of mitochondrial beta- 37 Queen Square oxidation of fatty acids. The mitochondrial trifunctional protein is composed of 4 alpha London, WC1N 3BH and 4 beta subunits, which are encoded by the HADHA and HADHB genes, respectively. It is characterized by early-onset cardiomyopathy, hypoglycemia, T +44 (0) 20 7762 6888 neuropathy, and pigmentary retinopathy, and sudden death. There is also an infantile F +44 (0) 20 7813 8578 onset form with a hepatic Reye-like syndrome, and a late-adolescent onset form with primarily a skeletal myopathy. Tandem mass spectrometry of organic acids in urine, Samples required and carnitines in blood spots, allows the diagnosis to be unequivocally determined. An 5ml venous blood in plastic EDTA additional clinical complication can occur in the pregnant mothers of affected fetuses; bottles (>1ml from neonates) they may experience maternal acute fatty liver of pregnancy (AFLP) syndrome or Prenatal testing must be arranged hypertension/haemolysis, elevated liver enzymes and low platelets (HELLP) in advance, through a Clinical syndrome. Genetics department if possible. The genes encoding the HADHA and HADHB subunits are located on chromosome Amniotic fluid or CV samples 2p23.3. The pathogenic
    [Show full text]
  • Is Glyceraldehyde-3-Phosphate Dehydrogenase a Central Redox Mediator?
    1 Is glyceraldehyde-3-phosphate dehydrogenase a central redox mediator? 2 Grace Russell, David Veal, John T. Hancock* 3 Department of Applied Sciences, University of the West of England, Bristol, 4 UK. 5 *Correspondence: 6 Prof. John T. Hancock 7 Faculty of Health and Applied Sciences, 8 University of the West of England, Bristol, BS16 1QY, UK. 9 [email protected] 10 11 SHORT TITLE | Redox and GAPDH 12 13 ABSTRACT 14 D-Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an immensely important 15 enzyme carrying out a vital step in glycolysis and is found in all living organisms. 16 Although there are several isoforms identified in many species, it is now recognized 17 that cytosolic GAPDH has numerous moonlighting roles and is found in a variety of 18 intracellular locations, but also is associated with external membranes and the 19 extracellular environment. The switch of GAPDH function, from what would be 20 considered as its main metabolic role, to its alternate activities, is often under the 21 influence of redox active compounds. Reactive oxygen species (ROS), such as 22 hydrogen peroxide, along with reactive nitrogen species (RNS), such as nitric oxide, 23 are produced by a variety of mechanisms in cells, including from metabolic 24 processes, with their accumulation in cells being dramatically increased under stress 25 conditions. Overall, such reactive compounds contribute to the redox signaling of the 26 cell. Commonly redox signaling leads to post-translational modification of proteins, 27 often on the thiol groups of cysteine residues. In GAPDH the active site cysteine can 28 be modified in a variety of ways, but of pertinence, can be altered by both ROS and 29 RNS, as well as hydrogen sulfide and glutathione.
    [Show full text]
  • How Is Alcohol Metabolized by the Body?
    Overview: How Is Alcohol Metabolized by the Body? Samir Zakhari, Ph.D. Alcohol is eliminated from the body by various metabolic mechanisms. The primary enzymes involved are aldehyde dehydrogenase (ALDH), alcohol dehydrogenase (ADH), cytochrome P450 (CYP2E1), and catalase. Variations in the genes for these enzymes have been found to influence alcohol consumption, alcohol-related tissue damage, and alcohol dependence. The consequences of alcohol metabolism include oxygen deficits (i.e., hypoxia) in the liver; interaction between alcohol metabolism byproducts and other cell components, resulting in the formation of harmful compounds (i.e., adducts); formation of highly reactive oxygen-containing molecules (i.e., reactive oxygen species [ROS]) that can damage other cell components; changes in the ratio of NADH to NAD+ (i.e., the cell’s redox state); tissue damage; fetal damage; impairment of other metabolic processes; cancer; and medication interactions. Several issues related to alcohol metabolism require further research. KEY WORDS: Ethanol-to­ acetaldehyde metabolism; alcohol dehydrogenase (ADH); aldehyde dehydrogenase (ALDH); acetaldehyde; acetate; cytochrome P450 2E1 (CYP2E1); catalase; reactive oxygen species (ROS); blood alcohol concentration (BAC); liver; stomach; brain; fetal alcohol effects; genetics and heredity; ethnic group; hypoxia The alcohol elimination rate varies state of liver cells. Chronic alcohol con- he effects of alcohol (i.e., ethanol) widely (i.e., three-fold) among individ- sumption and alcohol metabolism are on various tissues depend on its uals and is influenced by factors such as strongly linked to several pathological concentration in the blood T chronic alcohol consumption, diet, age, consequences and tissue damage. (blood alcohol concentration [BAC]) smoking, and time of day (Bennion and Understanding the balance of alcohol’s over time.
    [Show full text]
  • Dehydrogenase Classes
    Proc. Nati. Acad. Sci. USA Vol. 91, pp. 4980-4984, May 1994 Biochemistry Fundamental molecular differences between alcohol dehydrogenase classes (Drosophila octano dehydrogenase/class m alcohol dehydrogenase/mo ur patterns/zinc enyme famy) OLLE DANIELSSON*, SILVIA ATRIANt, TERESA LUQUEt, LARS HJELMQVIST*, ROSER GONZALEZ-DUARTEt, AND HANS J6RNVALL*f *Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 77 Stockholm, Sweden; tCenter for Biotechnology, Karolinska Institutet, S-141 86 Huddinge, Sweden; and tDepartment of Genetics, University of Barcelona, E-08071 Barcelona, Spain Communicated by Sune Bergstrom, January 18, 1994 ABSTRACT Two types of alcohol dehydrogenase in sepa- ary patterns, with class III being "constant" and class I rate protein families are the "medium-chain" zinc enzymes "variable" (10), result in a consistent picture of the enzyme (including the classical liver and yeast forms) and the "short- system and place the classes of medium-chain alcohol dehy- chain" enzymes (including the insect form). Although the drogenases as separate enzymes in the cellular metabolism. medium-chain family has been characterized in prokaryotes Similarly, another protein family, short-chain dehydroge- and many eukaryotes (fungi, plants, cephalopods, and verte- nases, has also evolved into a family comprising many brates), insects have seemed to possess only the short-chain different enzyme activities, including an alcohol dehydroge- enzyme. We have now also characterized a medium-chain nase (11). This form operates by means of a completely alcohol dehydrogenase in Drosophila. The enzyme is identical different catalytic mechanism and is related to mammalian to insect octanol dehydrogenase. It Is a typical class m alcohol prostaglandin dehydrogenases/carbonyl reductase (12).
    [Show full text]
  • Properties and Kinetic Analysis of UDP-Glucose Dehydrogenase from Group a Streptococci IRREVERSIBLE INHIBITION by UDP-CHLOROACETOL*
    THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 272, No. 6, Issue of February 7, pp. 3416–3422, 1997 © 1997 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Properties and Kinetic Analysis of UDP-glucose Dehydrogenase from Group A Streptococci IRREVERSIBLE INHIBITION BY UDP-CHLOROACETOL* (Received for publication, September 19, 1996, and in revised form, November 6, 1996) Robert E. Campbell‡§, Rafael F. Sala‡, Ivo van de Rijn¶, and Martin E. Tanner‡i From the ‡Department of Chemistry, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada and ¶Wake Forest University Medical Center, Winston-Salem, North Carolina 27157 UDP-glucuronic acid is used by many pathogenic bac- the capsule enables the bacteria to evade the host’s immune teria in the construction of an antiphagocytic capsule system (7, 8). Group A and C streptococci are mammalian that is required for virulence. The enzyme UDP-glucose pathogens that use UDPGDH in the synthesis of a capsule dehydrogenase catalyzes the NAD1-dependent 2-fold ox- composed of hyaluronic acid (a polysaccharide consisting of idation of UDP-glucose and provides a source of the alternating glucuronic acid and N-acetylglucosamine residues) acid. In the present study the recombinant dehydrogen- (9, 10). Many of the known strains of Streptococcus pneumoniae ase from group A streptococci has been purified and also use UDP-glucuronic acid in the construction of their po- found to be active as a monomer. The enzyme contains lysaccharide capsule (11), and it has recently been shown that no chromophoric cofactors, and its activity is unaffected UDPGDH is required for capsule production in S.
    [Show full text]
  • Xj 128 IUMP Glucose Substance Will Be Provisionally Referred to As UDPX (Fig
    426 Studies on Uridine-Diphosphate-Glucose By A. C. PALADINI AND L. F. LELOIR Instituto de Inve8tigacione&s Bioquimicas, Fundacion Campomar, J. Alvarez 1719, Buenos Aires, Argentina (Received 18 September 1951) A previous paper (Caputto, Leloir, Cardini & found that the substance supposed to be uridine-2'- Paladini, 1950) reported the isolation of the co- phosphate was uridine-5'-phosphate. The hydrolysis enzyme of the galactose -1- phosphate --glucose - 1 - product of UDPG has now been compared with a phosphate transformation, and presented a tenta- synthetic specimen of uridine-5'-phosphate. Both tive structure for the substance. This paper deals substances were found to be identical as judged by with: (a) studies by paper chromatography of puri- chromatographic behaviour (Fig. 1) and by the rate fied preparations of uridine-diphosphate-glucose (UDPG); (b) the identification of uridine-5'-phos- 12A UDPG phate as a product of hydrolysis; (c) studies on the ~~~~~~~~~~~~~(a) alkaline degradation of UDPG, and (d) a substance similar to UDPG which will be referred to as UDPX. UMP Adenosine UDPG preparation8 8tudied by chromatography. 0 UjDPX Paper chromatography with appropriate solvents 0 has shown that some of the purest preparations of UDP UDPG which had been obtained previously contain two other compounds, uridinemonophosphate 0 4 (UMP) and a substance which appears to have the same constitution as UDPG except that it contains an unidentified component instead of glucose. This Xj 128 IUMP Glucose substance will be provisionally referred to as UDPX (Fig. la). The three components have been tested for co- enzymic activity in the galactose-1-phosphate-- 0-4 -J UDPX glucose-l-phosphate transformation, and it has been confirmed that UDPG is the active substance.
    [Show full text]
  • Moldx : BCKDHB Gene Test
    Local Coverage Article: Billing and Coding: MolDX: BCKDHB Gene Test (A55099) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information CONTRACTOR NAME CONTRACT TYPE CONTRACT JURISDICTION STATE(S) NUMBER Noridian Healthcare Solutions, A and B MAC 01111 - MAC A J - E California - Entire State LLC Noridian Healthcare Solutions, A and B MAC 01112 - MAC B J - E California - Northern LLC Noridian Healthcare Solutions, A and B MAC 01182 - MAC B J - E California - Southern LLC Noridian Healthcare Solutions, A and B MAC 01211 - MAC A J - E American Samoa LLC Guam Hawaii Northern Mariana Islands Noridian Healthcare Solutions, A and B MAC 01212 - MAC B J - E American Samoa LLC Guam Hawaii Northern Mariana Islands Noridian Healthcare Solutions, A and B MAC 01311 - MAC A J - E Nevada LLC Noridian Healthcare Solutions, A and B MAC 01312 - MAC B J - E Nevada LLC Noridian Healthcare Solutions, A and B MAC 01911 - MAC A J - E American Samoa LLC California - Entire State Guam Hawaii Nevada Northern Mariana Islands Article Information General Information Article ID Original Effective Date Created on 12/19/2019. Page 1 of 6 A55099 10/17/2016 Article Title Revision Effective Date Billing and Coding: MolDX: BCKDHB Gene Test 12/01/2019 Article Type Revision Ending Date Billing and Coding N/A AMA CPT / ADA CDT / AHA NUBC Copyright Retirement Date Statement N/A CPT codes, descriptions and other data only are copyright 2018 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply. Current Dental Terminology © 2018 American Dental Association.
    [Show full text]
  • Ii- Carbohydrates of Biological Importance
    Carbohydrates of Biological Importance 9 II- CARBOHYDRATES OF BIOLOGICAL IMPORTANCE ILOs: By the end of the course, the student should be able to: 1. Define carbohydrates and list their classification. 2. Recognize the structure and functions of monosaccharides. 3. Identify the various chemical and physical properties that distinguish monosaccharides. 4. List the important monosaccharides and their derivatives and point out their importance. 5. List the important disaccharides, recognize their structure and mention their importance. 6. Define glycosides and mention biologically important examples. 7. State examples of homopolysaccharides and describe their structure and functions. 8. Classify glycosaminoglycans, mention their constituents and their biological importance. 9. Define proteoglycans and point out their functions. 10. Differentiate between glycoproteins and proteoglycans. CONTENTS: I. Chemical Nature of Carbohydrates II. Biomedical importance of Carbohydrates III. Monosaccharides - Classification - Forms of Isomerism of monosaccharides. - Importance of monosaccharides. - Monosaccharides derivatives. IV. Disaccharides - Reducing disaccharides. - Non- Reducing disaccharides V. Oligosaccarides. VI. Polysaccarides - Homopolysaccharides - Heteropolysaccharides - Carbohydrates of Biological Importance 10 CARBOHYDRATES OF BIOLOGICAL IMPORTANCE Chemical Nature of Carbohydrates Carbohydrates are polyhydroxyalcohols with an aldehyde or keto group. They are represented with general formulae Cn(H2O)n and hence called hydrates of carbons.
    [Show full text]
  • The Effects of Glucose, N-Acetylglucosamine, Glyceraldehyde and Other Sugars on Insulin Release in Vivo S
    Diabetologia 11,279-284 (1975) by Springer-Verlag 1975 The Effects of Glucose, N-Acetylglucosamine, Glyceraldehyde and Other Sugars on Insulin Release in Vivo S. J.H. Ashcroft and J.R. Crossley Department of Biochemistry, University of Bristol, England Received: February 18, 1975, and in revised form: April 28, 1975 Summary. The specificity for carbohydrates of insulin secretory duced hyperglycaemia, but peak insulin concentrations occurred responses in vivo was studied. Test sugars were injected via a left before any change in plasma glucose concentration. No evidence femoral vein cannula into conscious rats. Blood samples collected was obtained for a stimulatory effect of galactose on insulinrelease. over the ensuing 60 min via a left femoral arterial cannula were Infusion for 60 rain of N-acetylglucosarnine produced a sustained assayed for plasma insulin and glucose, and, in some experiments, elevated plasma insulin concentration and significant hypogly- for N-acetyl glucosamine. Whereas L-glucose or saline produced no caemia. The present in vivo results agree with previous in vitro significant changes in plasma insulin or glucose concentrations, observations, and could indicate a role for sugars other than glucose D-glucose, N-acetylglucosamine, D-glucosamine, fructose, D-glyc- in the regulation of insulin release. eraldehyde and DL-glyceraldehyde were potent secretagogues. Simultaneous injection of mannoheptulose abolished the insulin- Key words: N-acetylglucosamine, insulin release, glyceraldehy- otropic action of glucose and N-acetylglucosamine, but not of DL- de, glucose, glucosamine, fructose, galactose, mannoheptulose, glu- glyceraldehyde. Fructose, glucosamine, and DL-glyceraldehyde in- coreceptor. Detailed studies of the specificity of the insulin se- been conclusively established. Strong evidence for the cretory response to sugars have been performed with involvement of a metabolite has been provided by the mouse and rat islets of Langerhans in vitro [1, 2].
    [Show full text]